ERBB2 and breast cancer: The pathology report both confirmed a diagnosis of breast cancer (a ‘lumping’ of the tissue's characteristics as ‘cancerous’), but also provided information about the tumour's receptor status e.g. ER+, HER2- (the ‘splitting’ of their cancer into a particular subtype).